G2 Investment Partners Management’s BioTelemetry, Inc. BEAT Stock Holding History

G2 Investment Partners Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-95,756	Closed	-$3.16M	–	85
2017 Q3	$3.16M	Buy	95,756 +5,590	+6%	+$194K	1.25%	30
2017 Q2	$3.02M	Buy	+90,166	New	+$2.69M	1.34%	33
2016 Q4	–	Sell	-86,703	Closed	-$1.61M	–	103
2016 Q3	$1.61M	Sell	86,703 -53,363	-38%	-$1.01M	0.74%	43
2016 Q2	$2.28M	Buy	+140,066	New	+$2.06M	1.05%	31
2016 Q1	–	Sell	-56,189	Closed	-$656K	–	102
2015 Q4	$656K	Sell	56,189 -3,302	-6%	-$41.8K	0.2%	57
2015 Q3	$728K	Sell	59,491 -33,309	-36%	-$425K	0.27%	52
2015 Q2	$875K	Buy	92,800 +39,600	+74%	+$366K	0.32%	59
2015 Q1	$471K	Buy	+53,200	New	+$537K	0.18%	65

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

G2 Investment Partners Management's BEAT Position: Q4 2017 in Review

G2 Investment Partners Management sold out of BioTelemetry, Inc. (BEAT) in Q4 2017, closing a stake of 95,756 shares — an estimated $3.16M sold.

G2 Investment Partners Management first reported a position in BEAT in Q1 2015 and held it in 8 quarters. The position peaked at $3.16M in Q3 2017. 192 funds tracked by Wall St. Rank hold BEAT as of Q4 2017.

G2 Investment Partners Management reported no remaining BioTelemetry, Inc. position as of Q4 2017 after selling out during the quarter.
G2 Investment Partners Management sold 95,756 BioTelemetry, Inc. shares in Q4 2017, an estimated $3.16M.
G2 Investment Partners Management first reported a position in BioTelemetry, Inc. in Q1 2015 and held it in 8 quarters.
G2 Investment Partners Management's BioTelemetry, Inc. position peaked at $3.16M in Q3 2017.
192 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2017.

Based on G2 Investment Partners Management's 13F filing for Q4 2017, filed 14 Feb 2018.